Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

被引：0
作者：
Jiří Pavlů
Myriam Labopin
Riitta Niittyvuopio
Gerard Socié
Ibrahim Yakoub-Agha
Depei Wu
Peter Remenyi
Jakob Passweg
Dietrich W. Beelen
Mahmoud Aljurf
Nicolaus Kröger
Hélène Labussière-Wallet
Zinaida Perić
Sebastian Giebel
Arnon Nagler
Mohamad Mohty
机构：
[1] Imperial College London at Hammersmith Hospital,Centre for Haematology
[2] EBMT Paris Study Office/CEREST-TC/Saint Antoine Hospital,Department of Haematology
[3] HUCH Comprehensive Cancer Center,Stem Cell Transplantation Unit
[4] Saint Louis Hospital,Hematology–BMT
[5] Hopital Claude Huriez,Service des Maladies du Sang
[6] CHRU Lille,Department of Hematology
[7] the First Affiliated Hospital of Soochow University,Department of Bone Marrow Transplantation
[8] Délpesti Centrumkórház–Országos Hematológiai és Infektológiai Intézet,Department of Oncology
[9] University Hospital Basel,Bone Marrow Transplantation Centre
[10] University Hospital of Essen,Service d’hématologie
[11] King Faisal Specialist Hospital and Research Center,Zavod za hematologiju
[12] University Hospital Eppendorf,Division of Hematology and Bone Marrow Transplantation
[13] Centre Hospitalier Lyon Sud,undefined
[14] Klinika za unutarnje bolesti,undefined
[15] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[16] Chaim Sheba Medical Center,undefined
[17] Tel-Hashomer and Sackler School of Medicine,undefined
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
Measurable residual disease; Allogeneic hematopoietic cell transplantation; Acute lymphoblastic leukemia; Allogeneic; Myeloablative conditioning; Total body irradiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 107 条
  • [1] Berry DA(2017)Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis JAMA Oncol 3 e170580-4079
  • [2] Zhou S(1998)Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia Blood 92 4072-1672
  • [3] Higley H(2002)Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL Leukemia 16 1668-100
  • [4] Knechtli CJ(2007)Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia Pediatr Blood Cancer 48 93-618
  • [5] Goulden NJ(2007)Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia Haematologica 92 612-1195
  • [6] Hancock JP(2011)Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006 Biol Blood Marrow Transplant 17 1187-384
  • [7] Bader P(2009)Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM study group J Clin Oncol 27 377-1152
  • [8] Hancock J(2018)Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis BMC Cancer 18 755-1633
  • [9] Kreyenberg H(2018)Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the acute leukemia working party E Am J Hematol 93 1142-611
  • [10] Sramkova L(2009)Defining the intensity of conditioning regimens: working definitions Biol Blood Marrow Transplant 15 1628-273
12345678910